Review
doi: 10.1038/nrd1610.
Macro trends in pharmaceutical innovation
Affiliations
- PMID: 15688075
- DOI: 10.1038/nrd1610
Item in Clipboard
Review
Macro trends in pharmaceutical innovation
Nat Rev Drug Discov.
2005 Jan.
Abstract
Critics decry the lack of 'truly innovative' new medicines and question the role of the pharmaceutical industry in creating the few that are developed. Is this an accurate portrayal of the state of pharmaceutical innovation? Does major pharma still innovate? If so, how? Must the industry innovate to survive? These and related issues are discussed.
Similar articles
-
Could pharma open its drug freezers?Nat Rev Drug Discov. 2011 Jun;10(6):399-400. doi: 10.1038/nrd3473. Nat Rev Drug Discov. 2011. PMID: 21629278 No abstract available.
-
Aligning pharmaceutical innovation with medical need.Nat Med. 2007 Mar;13(3):304-8. doi: 10.1038/nm0307-304. Nat Med. 2007. PMID: 17342145 No abstract available.
-
Sending pharma better signals.Science. 2005 Jul 29;309(5735):669. doi: 10.1126/science.1117448. Science. 2005. PMID: 16051753 No abstract available.
-
Reducing impediments to technology transfer in drug abuse programming.NIDA Res Monogr. 1995;155:169-85. NIDA Res Monogr. 1995. PMID: 8594455 Review. No abstract available.
-
[Safety assessment of new products developed by the pharmaceutical industry].Ann Pharm Fr. 2001 Sep;59(5):324-30. Ann Pharm Fr. 2001. PMID: 11787426 Review. French.
Cited by
-
Can literature analysis identify innovation drivers in drug discovery?Nat Rev Drug Discov. 2009 Nov;8(11):865-78. doi: 10.1038/nrd2973. Nat Rev Drug Discov. 2009. PMID: 19876041 Free PMC article. Review.
-
The Current Status of Drug Discovery and Development as Originated in United States Academia: The Influence of Industrial and Academic Collaboration on Drug Discovery and Development.Clin Transl Sci. 2018 Nov;11(6):597-606. doi: 10.1111/cts.12577. Epub 2018 Jul 30. Clin Transl Sci. 2018. PMID: 29940695 Free PMC article.
-
Metabolomic profiling of drug responses in acute myeloid leukaemia cell lines.PLoS One. 2009;4(1):e4251. doi: 10.1371/journal.pone.0004251. Epub 2009 Jan 22. PLoS One. 2009. PMID: 19158949 Free PMC article.
-
The moderating role of absorptive capacity and the differential effects of acquisitions and alliances on Big Pharma firms' innovation performance.PLoS One. 2017 Feb 23;12(2):e0172488. doi: 10.1371/journal.pone.0172488. eCollection 2017. PLoS One. 2017. PMID: 28231332 Free PMC article.
-
How to improve R&D productivity: the pharmaceutical industry's grand challenge.Nat Rev Drug Discov. 2010 Mar;9(3):203-14. doi: 10.1038/nrd3078. Epub 2010 Feb 19. Nat Rev Drug Discov. 2010. PMID: 20168317 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
